Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gentem Health is a private healthcare technology company that develops software and services to help physician practices manage medical billing, revenue cycle operations, and reimbursement workflows. The company focuses on simplifying and accelerating insurance reimbursement for independent and small medical practices, using automation, data, and fintech-style payment infrastructure to improve cash flow and reduce administrative burden. Gentem has marketed end-to-end billing and reimbursement solutions rather than a therapeutic product pipeline, so it is best characterized as a commercial healthtech/RCM company rather than a biotech or pharma developer. Founded in 2019 in San Francisco, Gentem raised venture funding from investors including Susa Ventures and Vulcan Capital, and later appears to have become an acquired or merged operating subsidiary. Its offerings are aimed at helping providers remain financially viable while improving the patient financial experience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gentem Health.